More information: Jing Yang et al, MARTRE family proteins negatively regulate CCR4-NOT activity to protect poly(A) tail length and promote translation of maternal mRNA, Nature Communications (2025 ...
Tibumeshirnon is an oral immuno-oncology substance introduced by Hanmi Pharmaceutical from RAPT Therapeutics in 2019, which blocks the 'CCR4 receptor protein' that induces the movement of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback